1. Introduction {#sec1}
===============

Medicinal plants have been extensively used worldwide over history to treat and prevent the occurrence of several diseases, infections, and infestations in domestic animals, prevalently in livestock ([@bib1]; [@bib5]; [@bib16]; [@bib47]). The scientific interest in veterinary ethnopharmacology has increased since 2000\'s ([@bib31]), when a session at the 10^th^ International Congress of International Society for Ethnopharmacology ([@bib28]) was fully dedicated to different topics of veterinary ethnopharmacology, including the use of anthelminthic medicinal plants in livestock ([@bib31]). Unfortunately, to date the role of medicinal plants as anthelminthic strategy in veterinary medicine seems to be of scarce interest for the International Society for Ethnopharmacology ([@bib29]).

Certainly, ethnopharmacology may have a rationale in veterinary medicine due to the potential therapeutic efficacy, which is related with low risk of adverse events, reduced microbiological and parasitic resistance, and decreased residues in animal products and environment when compared to chemotherapeutic agents ([@bib1]). Despite some medicinal plants seem to have promising potential activity, to date only few and underpowered studies attempted to investigate the real efficacy profile of anthelminthic herbs in veterinary ethnopharmacology ([@bib1]; [@bib16]; [@bib37]).

Ethnoveterinary medicine represents an integral part of medical practices in most developing countries ([@bib16]; [@bib36]), and also in Europe a relevant number of plants used to treat organic livestock have been mapped, with some correspondence between the traditional empirical use and scientific evidence ([@bib37]).

In the light of this background, the hypothesis of this study is that medicinal plants may have effective anthelminthic activity in animals. Therefore, we have performed a qualitative synthesis of the current literature aimed to provide the geographical distribution of the use of anthelminthic medicinal plants in livestock in European Union (EU). We have also carried out a quantitative synthesis aimed to assess whether medicinal plants may really have in vivo anthelminthic effects in animals, and to compare the efficacy of anthelminthic medicinal plants with that of anthelminthic drugs.

2. Materials and methods {#sec2}
========================

2.1. Search strategy and study eligibility {#sec2.1}
------------------------------------------

The protocol of this synthesis of the current literature has been registered in the international prospective register of systematic reviews (PROSPERO, ID: CRD42019126353), and performed in agreement with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) ([@bib39]), with the flow diagram reported in [Figure 1](#fig1){ref-type="fig"}. This study satisfied all the recommended items reported by the PRISMA-P checklist ([@bib39]).Figure 1PRISMA flow diagram (A) for the identification of studies included in the network meta-analysis concerning the impact of anthelminthic medicinal plants in veterinary medicine compared to anthelminthic drugs and negative control. Diagram (B) displaying the network of the arms involved in the Bayesian analysis. The area including the treatments are related with the extent of population, and the numbers along the link lines indicate the number of animals comparing pairs of treatments.Figure 1

A comprehensive literature search was performed for studies written in English and concerning the use and efficacy of anthelminthic medicinal plants in veterinary medicine.

The studies eligible in the qualitative synthesis (systematic review) were the surveys that investigated the use of anthelminthic medicinal plants in livestock in the area of EU. The EU Countries considered for the qualitative synthesis (systematic review) at the time of studies search were: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom.

The studies eligible in the quantitative synthesis (network meta-analysis) where those that investigated the efficacy of anthelminthic medicinal plants in animals, namely both livestock and experimental animals. In this regard, the PICO (Patient problem, Intervention, Comparison, and Outcome) framework was applied to develop the literature search strategy and question, as previously reported ([@bib45]). Namely, the "Patient problem" included helminthic infestation in animals; the "Intervention" regarded the treatment with anthelminthic medicinal plants; the "Comparison" was performed versus either anthelminthic drugs or negative control, where the negative control could be both untreated animals and animals treated with placebo; the "Outcomes" were the faecal egg count and parasites count at necroscopy.

The search was performed in PubMed (MEDLINE), Scopus, and Web of Science (WOS), in order to provide for relevant studies published up to November 21, 2019. The research string was as follows: (ethno\[All Fields\] OR ("Tradition"\[Journal\] OR "tradition"\[All Fields\]) OR ("ethno"\[Journal\] OR "Folk"\[Journal\] OR "folk"\[All Fields\])) AND (("veterinary"\[Subheading\] OR "veterinary"\[All Fields\]) OR ("animals"\[MeSH Terms:noexp\] OR animal\[All Fields\]) OR ("livestock"\[MeSH Terms\] OR "livestock"\[All Fields\]) OR ("farms"MeSH Terms\] OR "farms"\[All Fields\] OR "farm"\[All Fields\]) OR ("sheep, domestic"\[MeSH Terms\] OR ("sheep"\[All Fields\] AND "domestic"\[All Fields\]) OR "domestic sheep"\[All Fields\] OR "sheep"\[All Fields\] OR "sheep"\[MeSH Terms\]) OR ("goats"\[MeSH Terms\] OR "goats'\[All Fields\] OR "goat"\[All Fields\]) OR ("cattle"\[MeSH Terms\] OR "cattle"\[All Fields\]) OR ("cattle"\[MeSH Terms\] OR "cattle"\[All Fields\] OR "cow"\[All Fields\]) OR ("swine"\[MeSH Terms\] OR "swine"\[All Fields\] OR "pig"\[All Fields\]) OR calve\[All Fields\] OR ("poultry"\[MeSH Terms\] OR "poultry"\[All Fields\])) AND (("plants"\[MeSH Terms\] OR "plants"\[All Fields\] OR "plant"\[All Fields\]) OR herb\[All Fields\] OR phyto\[All Fields\]).

2.2. Study selection {#sec2.2}
--------------------

The surveys reporting data concerning the use of anthelminthic medicinal plants in livestock living in EU were selected and included in the qualitative synthesis (systematic review). This selection approach was used to assess in which EU Countries there is scientific documentation of the current use of traditional medicinal plants in livestock.

The studies reporting data concerning the in vivo efficacy of any anthelminthic medicinal plants with respect to the reduction of faecal egg count or parasites count at necroscopy in animals, both livestock and experimental animals, were selected and included in the quantitative synthesis (meta-analysis).

Three reviewers independently examined the studies, and any difference in opinion concerning the selection of the studies was resolved by consensus.

2.3. Data extraction {#sec2.3}
--------------------

Data from the studies included in the quantitative synthesis were extracted and checked for study characteristics, host animals, parasites, number of analysed subjects, treatments (medicinal plants and comparators \[anthelminthic drugs and negative controls\]), outcomes, time-points, item to check the consistency with the Animal Research Reporting In Vivo Experiments (ARRIVE) guidelines ([@bib32]), and items to assess the quality of studies. Data were extracted in agreement with Data Extraction for Complex Meta-anALysis (DECiMAL) recommendations ([@bib42]) and at the time-points eliciting the maximal effect. When needed, arithmetic mean and standard deviation were estimated from the geometric mean, median, range and the sample size as previously described ([@bib26]).

2.4. Endpoints {#sec2.4}
--------------

The endpoint of the qualitative synthesis (systematic review) was to provide the geographical distribution of the use of anthelminthic medicinal plants in livestock specifically in the EU Countries.

The endpoint of the quantitative synthesis (meta-analysis) was to assess the in vivo anthelminthic efficacy of medicinal plants in animals compared to the effect elicited by anthelminthic drugs and negative control, regardless of the species and the origin of the origin of the medicinal plants.

2.5. Quality of studies, risk bias, and evidence profile {#sec2.5}
--------------------------------------------------------

The quality of each study included in the network meta-analysis was assessed by using the SYstematic Review Centre for Laboratory animal Experimentation Risk of Bias (SYRCLE RoB) tool, that is based on the Cochrane Collaboration tool, and has been adjusted for scoring the aspects of bias that play a specific role in animal intervention studies. SYRCLE RoB tool include 10 items to assess the selection, performance, attrition, and reporting bias. For each item yes, no, and unclear risk of bias corresponded to low, high, and unclear risk of bias, respectively ([@bib25]). Three reviewers, with a specific background in the field of quantitative synthesis, independently assessed the quality of the studies, and any difference in opinion concerning the SYRCLE RoB score was resolved by consensus.

The risk of bias in the network meta-analysis was checked via the normalized consistency/inconsistency analysis that permitted to assess whether the outcomes resulting from the consistency and inconsistency models fit adequately with the line of equality, as previously described ([@bib14]). The inconsistency of evidence was also assessed by quantifying the inconsistency factor, indicating whether one of the treatment had a different effect when it was compared with the others ([@bib13]).

The quality of the evidence was scored in agreement with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system ([@bib22]).

2.6. Data synthesis and analysis {#sec2.6}
--------------------------------

A network meta-analysis was performed to determine the anthelminthic effect of medicinal plants compared with anthelminthic drugs and negative control. The network meta-analysis permitted to rank the affect of different medicinal plants, drugs and negative control with regard to their anthelminthic activity, as previously described ([@bib12]). A full Bayesian evidence network was used in the network meta-analysis (chains: 4; initial values scaling: 2.5; tuning iterations: 20.000; simulation iterations: 50.000; tuning interval: 10). The convergence diagnostics for consistency and inconsistency were assessed via the Brooks-Gelman-Rubin method, as previously described ([@bib12]).

The output of network meta-analysis was the relative effect (RE) and 95% credible interval (95%CrI). The relative effect (RE) of overall network meta-analysis is reported as standardized mean difference (SMD = \[difference in mean outcome between groups\]\*\[standard deviation of outcome among participants\]-1), since the studies assessed the same outcome (anthelminthic effect) by measuring it in a variety of ways (i.e. faecal egg count or parasites count at necroscopy). SMD expresses the size of the intervention effect in each study relative to the variability observed in that study ([@bib24]).

Subset network meta-analysis were performed on the anthelminthic effect of specific medicinal plants vs. control by considering the same outcome. In this circumstance the RE was reported as mean difference (MD) ([@bib23]).

The probability that each specific medicinal plant, drug and negative control were the most effective was calculated by counting the proportion of iterations of the chain in which each treatment had the highest RE, and the surface under the cumulative ranking curve analysis (SUCRA), representing the summary of these probabilities, was also calculated ([@bib15]). The SUCRA is 1 when a treatment is considered to be the best, and 0 when a treatment is considered to be the worst ([@bib14]).

The statistical significance was assessed for P \< 0.05. The GeMTC ([@bib52]) software were used for performing the network meta-analysis, GraphPad Prism (CA, US) software to graph the data, and GRADEpro GDT to assess the quality of evidence ([@bib22]).

3. Results {#sec3}
==========

3.1. Qualitative synthesis {#sec3.1}
--------------------------

Twelve studies reported data from survey studies that investigated the use of anthelminthic medicinal plants in livestock living in EU Countries ([@bib7]; [@bib9], [@bib10]; [@bib17]; [@bib18]; [@bib19]; [@bib20]; [@bib27]; [@bib43]; [@bib44]; [@bib51]; [@bib54]). Of these studies 9, 2 and 1 investigations were conducted in Italy, Spain, and Austria, respectively. Details on specific regions, sub-regions, and livestock species are shown in [Table 1](#tbl1){ref-type="table"}.Table 1Qualitative synthesis of survey studies that investigated the use of anthelminthic medicinal plants in livestock living in EU Countries.Table 1Author and yearCountryRegionSub-regionLivestockBos taurusOvis ariesSus scrofa domesticusEquus caballusOryctolagus cuniculusCapra aegagrus hircusGallus gallus domesticusMeleagris gallopavoEquus asinus × Equus caballusEquus asinus([@bib10])ItalySardiniaNAX/XX//X///([@bib54])AustriaEastern TyrolNAXXXX/XX///([@bib44])ItalySardiniaNA/X///X////([@bib17])SpainArribes del DueroNAXXXXXXX/XX([@bib27])ItalyAbruzzi, Lazio and MoliseAlto Sangro, Fucino plane, Lazio and MainardeXXXXX/////([@bib18])ItalyCampaniaSannioX/XXXXX//X([@bib7])SpainCataloniaNAXXXXX/XXX/([@bib9])ItalySardiniaNAXXXXXXXX//([@bib20])ItalyBasilicataMarateaXX//XX////([@bib43])ItalyBasilicataDolomiti LucaneXXX/XXX///([@bib51])ItalyTuscanyNAXXXXXXXXX/([@bib19])ItalyMarche, Abruzzi, LatiumNAXXXXX/////[^2]

3.2. Quantitative synthesis {#sec3.2}
---------------------------

### 3.2.1. Studies and population characteristics {#sec3.2.1}

Data obtained from 256 animals (48.05% in the anthelminthic medicinal plants arm, 24.61% in the anthelminthic drugs arm, and 27.34% in the negative control arm) were extracted from 6 studies ([@bib4]; [@bib21]; [@bib30]; [@bib41]; [@bib48]; [@bib50]). The species used in the in vivo experimental settings were *Mus musculus* ([@bib4]; [@bib21]; [@bib50]), *Meriones unguiculatus* ([@bib41]), *and Ovis aries* ([@bib30]; [@bib48]). All the studies investigated the impact of anthelminthic medicinal plants, anthelminthic drugs and negative control on gastrointestinal nematodes. The period of treatment ranged from 1 day to 1 week.

Although all the studies included in this quantitative synthesis enrolled animals used for experimental purpose, none of the studies have been performed in agreement with the ARRIVE guidelines ([@bib32]). Detailed studies design, hosts, parasites, treatments, outcomes, and time-points are reported in [Table 2](#tbl2){ref-type="table"}.Table 2Study characteristics.Table 2Author and yearStudy designHost animalParasitesNumber of analysed animalsTreatments[∗](#tbl2fnlowast){ref-type="table-fn"}OutcomesTime-pointConsistency with ARRIVE guidelinesMedicinal plantsComparatorsAnthelminthic drugsNegative controls([@bib21])In vivo experimental study, active and negative control, 5 arms, parallel-group, randomized*Mus musculusSyphacia obvelata; Aspiculuris tetraptera*60*Polygonum cognatum* (dose: 100 mg/kg; days of treatment: 1; regimen: single dose administration; vehicle: n-hexane extract, EtOAc extract, MeOH extract)Doramectin (dose: 0.2 mg/kg; regimen: single dose administration)CMC suspensionParasite counts recovered at necropsyDay 7 post-treatmentNO([@bib50])In vivo experimental study, active and negative control, 5 arms, parallel-group, randomized*Mus musculusHeligmosomoides bakeri*25*Duranta erecta* (doses: 250-500-1000 mg/kg; days of treatment: 1; regimen: single dose administration; vehicle: MeOH extract)Albendazole (dose: 25 mg/kg; regimen: single dose administration)UntreatedParasite counts recovered at necropsyDay 28 post-infectionNO([@bib30])In vitro and in vivo experimental study, active and negative control, 3 arms, parallel-group*Ovis ariesHaemonchus contortus*45*Allium sativum* (dose: 5 g/animal; days of treatment: 1; regimen: single dose administration; vehicle: aqueous extract)Albendazole (dose: 7.5 mg/kg; regimen: single dose administration)UntreatedFaecal egg countDay 21 post-treatmentNO([@bib41])In vitro and in vivo experimental study, active and negative control, 6 arms, parallel-group*Meriones unguiculatusHaemonchus contortus*42*Allium sativum* and *Tagetes erecta* (dose: 40 mg/mL in 100 μL volume; days of treatment: 1; regimen: single dose administration; vehicle: n-hexane extract, acetone extract)Fenbendazole (dose: NA; regimen: NA)Distilled water; tween-20 3%Parasite counts recovered at necropsyDay 13 post-infectionNO([@bib4])In vivo experimental study, active and negative control, 3 arms, parallel-group*Mus musculusAspiculuris tetraptera*54*Allium sativum* (dose: one garlic clove/mouse; days of treatment: 7; regimen: once-daily; vehicle: garlic liquid suspension)Ivermectin (dose: 0.2 mg/kg; regimen: NA)NaCl 0.9%Parasites counts recovered at necropsyDay 8 post-treatmentNO([@bib48])In vitro and in vivo experimental study, active and negative control, 6 arms, parallel-group, randomized*Ovis ariesHaemonchus contortus*30*Artemisia absinthium* (doses: 1--2 g/kg; days of treatment: 1; regimen: single dose administration; vehicle: crude aqueous extract, crude ethanolic extract)Albendazole (dose: 5 mg/kg; regimen: single dose administration)DMSO 0.5%Faecal egg counts/g of faecesDay 15 post-treatmentNO[^3][^4]

### 3.2.2. Network meta-analysis {#sec3.2.2}

The overall network meta-analysis indicated that the anthelminthic effect of medicinal plants and drugs was significantly (P \< 0.001) more effective than that elicited by negative control (SMD: -0.60 95%CrI -0.88 to -0.31, -0.73 95%CrI -1.08 to -0.38; respectively), and no significant difference (P \> 0.05) was detected between anthelminthic medicinal plants and anthelminthic drugs (SMD: 0.26 95%CrI -0.02 to 0.55) ([Figure 2](#fig2){ref-type="fig"}A).Figure 2Overall forest plot of network meta-analysis (A) concerning the comparison of anthelminthic efficacy across medicinal plants, drugs and negative control; anthelminthic ranking plot (B) resulting from the network meta-analysis of specific medicinal plants, drugs and negative control in which each treatment was plotted on X-axis according to SUCRA (score of 1 being the most effective) and on Y-axis according to the probability (%) of being the best treatment. \*\*\*P \< 0.001 vs. comparator. CrI: credible interval; SMD: standardized mean difference; SUCRA: surface under the cumulative ranking curve analysis.Figure 2

The results of the overall network meta-analysis were confirmed by the SUCRA ranking, in which both albendazole, *Artemisia absintihium*, and *Allium sativum* were located in the upper ranking quartile, as well as *Duranta erecta* resulted to have the same anthelminthic efficacy of ivermectin and fenbendazole (third quartile in SUCRA ranking), followed by doramectin, *Allium sativum* plus *Tagetes erecta*, *and Tagetes erecta* (second quartile in SUCRA ranking), and finally *Polygonum cognatum* and negative control (first quartile in SUCRA ranking). Overall, the most effective anthelminthic medicinal plants were *Artemisia absintihium*, *Allium sativum*, and *Duranta erecta* ([Figure 2](#fig2){ref-type="fig"}B).

The results of the subset network meta-analysis were performed on the anthelminthic effect of specific medicinal plants vs. negative control by considering the same outcome are reported in [Table 3](#tbl3){ref-type="table"}.Table 3Anthelminthic effect of specific medicinal plants compared to negative control. Data are reported as MD because the data resulted from the network meta-analysis of treatment arms that assessed the anthelminthic effect on the same outcome.Table 3Medicinal plantsAnthelminthic effect vs. negative control (MD and 95%CrI)Outcome*Artemisia absinthium*-514.18 (-591.07, -437.29)\*\*\*Faecal egg count*Allium sativum*-71.64 (-86.20, -57.08)\*\*\*Parasites count at necropsy*Tagetes erecta*-55.64 (-83.49, -27.80)\*\*\*Parasites count at necropsy*Polygonum cognatum*-30.10 (-56.62, -3.58)\*Parasites count at necropsy*Duranta erecta*-10.33 (-20.61, -0.05)\*Parasites count at necropsy[^5][^6]

### 3.2.3. Quality of studies, risk bias, and evidence profile {#sec3.2.3}

The studies included in the quantitative synthesis may have bee affected by a certain level of selection bias and performance bias, although 4 studies adequately reported the baseline characteristics of animals and 3 studies indicated that the housing was randomly assigned. Conversely, it was unclear for all the studies whether there was any form of detection bias. In any case, no attrition bias and reporting bias was detected, as well as other source of bias. Detailed findings resulting from the SYRCLE RoB tool are reported in [Figure 3](#fig3){ref-type="fig"}.Figure 3SYRCLE RoB assessment for the studies included in the network meta-analysis. ?: unclear risk of bias; +: low risk of bias; -: high risk of bias; RoB: risk of bias.Figure 3

The level of uncertainty resulting from the SYRCLE RoB tool was confirmed by the normalized consistency/inconsistency analysis resulting from the network comparison across specific medicinal plants, drugs and negative control, in which a certain number of points did not fit adequately with the line of equality, as confirmed by the linear regression model (goodness of fit: R^2^ 0.71; slope 0.93 95% confidence intervals 0.82 to 1.04) ([Figure 4](#fig4){ref-type="fig"}), and by a significant (P \< 0.05) inconsistency factor in the evidence cycle including albendazole, *Allium sativum*, *Allium sativum* plus *Tagetes erecta*, *Artemisia absintihium*, fenbendazole, and negative control. Conversely, no significant (P \> 0.05) inconsistency factor was detected in the evidence cycles including albendazole, *Allium sativum*, *Allium sativum* plus *Tagetes erecta*, *Duranta erecta*, fenbendazole, and negative control, or *Allium sativum*, *Allium sativum* plus *Tagetes erecta*, fenbendazole, and negative control, or *Allium sativum* plus *Tagetes erecta*, fenbendazole, *Tagetes erecta* and negative control.Figure 4Publication bias assessment via the normalized consistency/inconsistency plot (linear regression and 95% confidence bands) for the comparison of anthelminthic effect across specific medicinal plants, drugs and negative control.Figure 4

The GRADE analysis indicated moderate quality of evidence (+++) for the overall network meta-analysis concerning the comparison across medicinal plants, drugs, and negative control with respect to the comparison of their anthelminthic effect.

4. Discussion {#sec4}
=============

The qualitative synthesis of the current literature regarding the geographical distribution of the use of anthelminthic medicinal plants in livestock indicates that, across the EU Countries, the most investigations were performed in Italy (9 survey studies), followed by Spain (2 survey studies), and Austria (1 survey study). No further papers are currently available for the remaining EU Countries but, considering that it is extensively recognized that the absence of evidence is not evidence of absence ([@bib2]; [@bib3]), we cannot exclude that medicinal plants are, or have been, used in further area of EU for anthelminthic purpose in livestock.

Such an effort in performing numerous survey studies moved generally from the empirical knowledge that Mediterranean farmers in EU traditionally used plants sourced locally to treat their animals ([@bib10]; [@bib51]). Nevertheless, only in 2014 there was an attempt to systematically report the studies concerning the ethnoveterinary of medicinal plants to treat organic livestock use in EU ([@bib37]). Although the paper of Mayer and colleagues was of interest ([@bib37]), the qualitative synthesis of literature that they provided was not performed in agreement with the recommendation available at that time (PRISMA statement) for the development and reporting of systematic review ([@bib38]), and no quantitative synthesis (meta-analysis) was performed.

Considering this background, we have conducted a quantitative synthesis in agreement with the PRISMA-P and PROSPERO recommendations ([@bib39]) concerning the current literature on the anthelminthic effect of medicinal plants in veterinary medicine. The full Bayesian network approach used in our study permitted not only to assess the anthelminthic effect of medicinal plants, but also and most importantly to compare the anthelminthic effect of medicinal plants with the efficacy of anthelminthic drugs.

The results of our study shows that the overall anthelminthic effect of the medicinal plants included in the network meta-analysis was significantly greater compared to negative control and, as expected, that also anthelminthic drugs were more effective than negative control. Surprisingly, our analysis suggests that the overall efficacy of anthelminthic medicinal plants was similar to that of anthelminthic drugs. These findings are further confirmed by the rank resulting from the SUCRA concerning each specific treatment arm, in which *Artemisia absintihium*, *Allium sativum*, and *Duranta erecta*, that were the most effective anthelminthic medicinal plants, reached the same efficacy of albendazole, ivermectin and fenbendazole (two upper quartiles).

Indeed, the result of this quantitative synthesis should draw the attention of the scientific community: here we provide for the first time the evidence of a potential new paradigm that the infestation by nematodes in animals can be effectively treated with the extracts of medicinal plants. We can further extend this concept by hypothesizing that the gastrointestinal helminthic infestation could be naturally controlled in livestock grazing in pastures rich in medicinal plants such as *Artemisia absintihium* and, thus, reduce the use of anthelminthic drugs. This is certainly of interest for breeding organic livestock, and might also help to reduce the potential environmental risk due to the extensive use of anthelminthic agents ([@bib35]).

The last report concerning the environmental risks of medicinal products ([@bib40]) has highlighted that the most extensive use of avermectins is in the control of livestock parasites. This evidence supports the fact that the global antiparasitic veterinary market represents 28% of the global EU veterinary medicine marketing, that is equivalent to 1.2 billion Euros ([@bib46]). It is impressive that, since its market introduction in the early 1980s, ivermectin has become the most widely used antiparasitic drug with over 5 billion doses sold worldwide until 2000s ([@bib46]). Such an extensive and uncontrolled use of antiparasitic agents has raised relevant concerns, supported by scientific evidence, regarding the parasitic resistance and the environmental impact related with the use of avermectins ([@bib34]; [@bib35]). Therefore, considering that the extracts of *Artemisia absintihium*, *Allium sativum*, and *Duranta erecta* seem to be as effective as ivermectin, a drug ranked in EU in the top four ecotoxic substances and for which parasitic resistance is increasing ([@bib8]; [@bib33]), shifting the antiparasitic therapy towards the use of anthelminthic medicinal plants could reduce the residue of macrocyclic lactones in terrestrial and aquatic environments and prevent future resistance ([@bib35]; [@bib49]).

Indeed this study has limitations, the most important of which is the moderate quality of evidence resulting from the GRADE analysis, a method that provides explicit criteria for rating the quality of evidence by assessing study design, risk of bias, imprecision, inconsistency, indirectness, and magnitude of effect ([@bib22]). This means that we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. In other words, further investigations are likely to have an important impact on the 95%CrI and may change the RE reported in this research ([@bib6]). Certainly, performing animal research in agreement with the ARRIVE guidelines ([@bib32]) influences the quality of each single study and, thus, may improve the quality of evidence of meta-analyses ([@bib53]). Furthermore, across the studies included in the network meta-analysis, only two were carried out by enrolling livestock ([@bib30]; [@bib48]), whereas the most were performed in rodents ([@bib21]; [@bib41]; [@bib48]; [@bib50]). Unexpectedly, data from SUCRA shown in [Figure 2](#fig2){ref-type="fig"}B indicate that the combination of *Allium sativum* plus *Tagetes erecta* was less effective than the extract of *Allium sativum* alone, suggesting for a potential antagonistic interaction between the extracts of *Allium sativum* and *Tagetes erecta*.

5. Conclusion {#sec5}
=============

This study provides the evidence that medicinal plants are as effective as drugs against helminthic infestation in animals, and that *Artemisia absintihium*, *Allium sativum*, and *Duranta erecta* are the most effective anthelminthic medicinal plants. The findings of this study suggest that there is the strong medical need of performing adequately powered randomized controlled trials in different livestock species (cattle, pigs, sheep, and horses), and eventually in pets (dogs and cats), aimed to improve the quality of the current evidence concerning the anthelminthic efficacy of medicinal plants compared to that of the currently available antiparasitic drugs. Finally, but not less important, the future randomized controlled trials should be designed to provide also information on the pharmacological interaction across the extracts of different anthelminthic medicinal plants that may lead either to synergistic or antagonistic effect ([@bib11]).
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